Revvity stock heads into the open after a 9.1% jump to a new high
Published on 09/16/2026 at 07:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Revvity stock closed at USD 140.19 on the NYSE on September 15, 2026, up 9.1% from the prior close of USD 128.49. The rally carried the shares to a new 52-week high around USD 140.22, significantly outpacing the major US indices on the same day.
September 15, 2026 in numbers
Revvity Inc. (ISIN US76155R1086, NYSE: RVTY) saw its shares rise to an end-of-day level of USD 140.19 on September 15, 2026, compared with a previous close of USD 128.49, marking a daily gain of 9.1%. According to data cited by GuruFocus, that closing price left the stock just below its 52-week high of USD 140.22 on the same day. A separate price wrap from Economic Times likewise lists Revvity at USD 140.19 with a 9.11% advance in the US end-of-day quote for September 15, 2026, corroborating the session profile. In intraday trading the shares moved near the top of the daily range and were highlighted among the biggest movers, with CNBC noting a roughly 7% intraday gain and a fresh 52-week high as of midday on September 15, 2026.
The stock’s strong move contrasted with the broader US market, where large-cap indices posted far smaller changes on September 15, 2026. While detailed index figures vary by source, the combination of a 9.1% daily advance and a close almost exactly at the 52-week high underlines how markedly Revvity outperformed typical benchmark returns in that session. Market commentary from MarketBeat described the close as a new one-year high and pointed to the stock’s momentum relative to its recent trading history.
Outlook today after margin-focused guidance
The primary driver behind the September 15, 2026 surge was updated profitability guidance discussed at a major healthcare conference. As TipRanks reported on September 15, 2026, Revvity shares climbed after management used a global healthcare conference to outline a more profitable future, including targeted operating margins in the upper 20s percent range by 2026 and cash flow conversion above 90 percent. That margin-focused message came alongside commentary on demand trends and backlog, and was reinforced by Revvity’s participation in the 2026 Global Healthcare Conference, as reflected in the event transcript published by Seeking Alpha dated September 15, 2026.
Heading into today’s US session on September 16, 2026, investors are set to digest that margin guidance alongside ongoing commentary from analysts and conference participants. The conference-related remarks, including discussion of growth, artificial intelligence initiatives and order backlog highlighted by Investing.com on September 15, 2026, remain key reference points for sentiment today. Any further analyst reactions or follow-up commentary linked to those margin targets and growth themes could influence Revvity’s trading pattern in the upcoming session, especially given that the shares now sit just below their newly established 52-week high.
